GSS
Basic information
Region (hg38): 20:34928432-34956027
Links
Phenotypes
GenCC
Source: 
- glutathione synthetase deficiency with 5-oxoprolinuria (Strong), mode of inheritance: AR
 - inherited glutathione synthetase deficiency (Definitive), mode of inheritance: AR
 
Clinical Genomic Database
Source: 
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References | 
|---|---|---|---|---|---|
| Glutathione synthetase deficiency | AR | Biochemical;Hematologic; Pharmacogenomic | Medical therapy (eg, N-acetylcysteine, vitamin E), may improve outcomes, especially if administered early; Hemolysis-causing drugs should be avoided; Acidosis can be medically corrected | Biochemical; Hematologic; Neurologic; Ophthalmologic | 13731008; 5901982; 5486400; 5476481; 481537; 3944259; 2502672; 1770788; 1986110; 7937585; 8896573; 11445798; 15717202; 15990954; 16435214; 17206463; 17479648; 19728142; 21988557 | 
ClinVar
This is a list of variants' phenotypes submitted to 
- Glutathione_synthetase_deficiency_with_5-oxoprolinuria (280 variants)
 - not_provided (109 variants)
 - Inborn_genetic_diseases (74 variants)
 - Inherited_glutathione_synthetase_deficiency (54 variants)
 - Glutathione_synthetase_deficiency_without_5-oxoprolinuria (24 variants)
 - not_specified (18 variants)
 - GSS-related_disorder (5 variants)
 - Schizophrenia (1 variants)
 - See_cases (1 variants)
 
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GSS gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000178.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum | 
|---|---|---|---|---|---|---|
| synonymous | 127 | 127 | ||||
| missense | 119 | 136 | ||||
| nonsense | 10 | 19 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 17 | |||||
| splice donor/acceptor (+/-2bp) | 8 | |||||
| Total | 17 | 32 | 123 | 136 | 0 | 
Highest pathogenic variant AF is 0.00011462475
GnomAD
Source: 
| Gene | Type | Bio Type | Transcript | Coding Exons | Length | 
|---|---|---|---|---|---|
| GSS | protein_coding | protein_coding | ENST00000216951 | 12 | 27385 | 
| pLI Probability LOF Intolerant  | pRec Probability LOF Recessive  | Individuals with no LOFs  | Individuals with Homozygous LOFs  | Individuals with Heterozygous LOFs  | Defined | p | 
|---|---|---|---|---|---|---|
| 0.00000176 | 0.993 | 125641 | 0 | 107 | 125748 | 0.000426 | 
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.774 | 227 | 262 | 0.865 | 0.0000160 | 3049 | 
| Missense in Polyphen | 88 | 100.51 | 0.87551 | 1197 | ||
| Synonymous | 1.11 | 93 | 108 | 0.864 | 0.00000625 | 988 | 
| Loss of Function | 2.43 | 14 | 27.9 | 0.502 | 0.00000176 | 282 | 
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p | 
|---|---|---|
| African & African-American | 0.000326 | 0.000326 | 
| Ashkenazi Jewish | 0.00447 | 0.00447 | 
| East Asian | 0.000490 | 0.000489 | 
| Finnish | 0.0000462 | 0.0000462 | 
| European (Non-Finnish) | 0.000290 | 0.000290 | 
| Middle Eastern | 0.000490 | 0.000489 | 
| South Asian | 0.000163 | 0.000163 | 
| Other | 0.000815 | 0.000815 | 
dbNSFP
Source: 
- Disease
 - DISEASE: Glutathione synthetase deficiency (GSS deficiency) [MIM:266130]: Severe form characterized by an increased rate of hemolysis and defective function of the central nervous system. {ECO:0000269|PubMed:27581854, ECO:0000269|PubMed:8896573, ECO:0000269|PubMed:9215686}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glutathione synthetase deficiency of erythrocytes (GLUSYNDE) [MIM:231900]: Mild form causing hemolytic anemia. Note=The disease is caused by mutations affecting the gene represented in this entry.;
 - Pathway
 - Glutathione metabolism - Homo sapiens (human);Cysteine and methionine metabolism - Homo sapiens (human);Ferroptosis - Homo sapiens (human);2-Hydroxyglutric Aciduria (D And L Form);Gamma-glutamyl-transpeptidase deficiency;5-oxoprolinase deficiency;Gamma-Glutamyltransferase Deficiency;Glutathione Metabolism;Homocarnosinosis;Hyperinsulinism-Hyperammonemia Syndrome;Glutathione Synthetase Deficiency;Succinic semialdehyde dehydrogenase deficiency;4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency;5-Oxoprolinuria;Glutamate Metabolism;Glutathione metabolism;Trans-sulfuration and one carbon metabolism;Amino Acid metabolism;One carbon metabolism and related pathways;Metapathway biotransformation Phase I and II;Glutathione conjugation;Phase II - Conjugation of compounds;Glutamate Glutamine metabolism;Biological oxidations;Metabolism;glutathione biosynthesis;γ-glutamyl cycle;Glutathione synthesis and recycling 
(Consensus)  
Recessive Scores
- pRec
 - 0.328
 
Intolerance Scores
- loftool
 - 0.256
 - rvis_EVS
 - -0.56
 - rvis_percentile_EVS
 - 19.73
 
Haploinsufficiency Scores
- pHI
 - 0.266
 - hipred
 - N
 - hipred_score
 - 0.443
 - ghis
 - 0.543
 
Essentials
- essential_gene_CRISPR
 - E
 - essential_gene_CRISPR2
 - N
 - essential_gene_gene_trap
 - K
 - gene_indispensability_pred
 - E
 - gene_indispensability_score
 - 0.665
 
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium | 
| Primary Immunodeficiency | Medium | Medium | Medium | 
| Cancer | Medium | Medium | Medium | 
Mouse Genome Informatics
- Gene name
 - Gss
 - Phenotype
 - mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
 
Gene ontology
- Biological process
 - cellular amino acid metabolic process;glutathione biosynthetic process;response to oxidative stress;nervous system development;aging;response to xenobiotic stimulus;response to nutrient levels;response to tumor necrosis factor;response to amino acid;response to cadmium ion
 - Cellular component
 - cytosol;extracellular exosome
 - Molecular function
 - magnesium ion binding;glutathione synthase activity;protein binding;ATP binding;glycine binding;identical protein binding;protein homodimerization activity;glutathione binding